Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
Kohler P, Wolfensberger A, Stampf S, Brönnimann A, Boggian K, van Delden C, Favre M, Hirzel C, Khanna N, Kuster SP, Manuel O, Neofytos D, Ragozzino S, Schreiber PW, Walti L, Mueller NJ; Swiss Transplant Cohort Study. Kohler P, et al. Among authors: ragozzino s. Antimicrob Resist Infect Control. 2021 Mar 7;10(1):50. doi: 10.1186/s13756-021-00918-7. Antimicrob Resist Infect Control. 2021. PMID: 33678189 Free PMC article.
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.
Ragozzino S, Goldenberger D, Wright PR, Zimmerli S, Mühlethaler K, Neofytos D, Riat A, Boggian K, Nolte O, Conen A, Fankhauser H, Schreiber PW, Zbinden R, Lamoth F, Khanna N. Ragozzino S, et al. Open Forum Infect Dis. 2021 Dec 18;9(2):ofab638. doi: 10.1093/ofid/ofab638. eCollection 2022 Feb. Open Forum Infect Dis. 2021. PMID: 35111868 Free PMC article.
Patients exposed to vancomycin-resistant enterococci during in-hospital outbreaks in a low endemic setting: a proposal for risk-based screening.
Büchler AC, Ragozzino S, Wicki M, Spaniol V, Jäger S, Seth-Smith HMB, Goldenberger D, Hinic V, Egli A, Frei R, Widmer AF. Büchler AC, et al. Among authors: ragozzino s. Antimicrob Resist Infect Control. 2022 Apr 13;11(1):60. doi: 10.1186/s13756-022-01089-9. Antimicrob Resist Infect Control. 2022. PMID: 35418099 Free PMC article.
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation.
Capoferri G, Walti CS, Urwyler P, Ragozzino S, Passweg JR, Halter J, Battegay M, Baettig V, Weisser M, Arnold B, Morin B, Guetlin Y, Torres DA, Barut GT, Thiel V, Egli A, Drexler B, Khanna N. Capoferri G, et al. Among authors: ragozzino s. Bone Marrow Transplant. 2023 May;58(5):597-599. doi: 10.1038/s41409-023-01936-2. Epub 2023 Feb 16. Bone Marrow Transplant. 2023. PMID: 36797421 Free PMC article. No abstract available.
Epidemiology of patients harboring carbapenemase-producing bacteria and comparison with patients with detection of extended-spectrum beta-lactamase-producing Enterobacterales-A retrospective cohort study.
Vock I, Aguilar-Bultet L, Goldenberger D, Ragozzino S, Kuster S, Tschudin-Sutter S. Vock I, et al. Among authors: ragozzino s. Infect Control Hosp Epidemiol. 2023 Dec;44(12):1959-1965. doi: 10.1017/ice.2023.125. Epub 2023 Jul 10. Infect Control Hosp Epidemiol. 2023. PMID: 37424228 Free PMC article.
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study.
Ragozzino S, Mueller NJ, Neofytos D, Passweg J, Müller A, Medinger M, Van Delden C, Masouridi-Levrat S, Chalandon Y, Tschudin-Sutter S, Khanna N; Swiss Transplant Cohort Study. Ragozzino S, et al. Bone Marrow Transplant. 2024 Feb;59(2):278-281. doi: 10.1038/s41409-023-02157-3. Epub 2023 Nov 30. Bone Marrow Transplant. 2024. PMID: 38036657 Free PMC article. No abstract available.
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M, Frossard J, Kouyos R, Prendki V, Damas J, Hofmann E, Braun D, Schmid P, Bernasconi E, Ragozzino S, Efthimiou O, Delpierre C, Allavena C, Bani-Sadr F, Calmy A; Swiss HIV Cohort Study. Hentzien M, et al. Among authors: ragozzino s. HIV Med. 2024 Jan;25(1):72-82. doi: 10.1111/hiv.13534. Epub 2023 Aug 24. HIV Med. 2024. PMID: 37619609 Free article.
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial.
Smit M, Marinosci A, Nicoletti GJ, Perneger T, Ragozzino S, Andrey DO, Stoeckle M, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Back M, Schaubhut C, Fuchs S, Decosterd L, Battegay M, Guessous I, Chappuis F, Kaiser L, Labhardt ND, Calmy A. Smit M, et al. Among authors: ragozzino s. BMJ Open. 2020 Nov 12;10(11):e040110. doi: 10.1136/bmjopen-2020-040110. BMJ Open. 2020. PMID: 33184083 Free PMC article.
Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB).
Hernández-García I, Ragozzino S, Giménez-Júlvez T. Hernández-García I, et al. Among authors: ragozzino s. Hum Vaccin Immunother. 2020 Oct 2;16(10):2513-2517. doi: 10.1080/21645515.2020.1726683. Epub 2020 Mar 2. Hum Vaccin Immunother. 2020. PMID: 32118514 Free PMC article.
18 results